Daniel G. Aaron, I. Glenn Cohen & Eli Y. Adashi, Lawsuits Over the Price of Insulin—State Efforts for Insulin Access, 184 JAMA Internal Med. 9 (2024).
Abstract: This Viewpoint discusses the litigation strategy of state-initiated lawsuits alleging illegal and immoral conduct regarding the pricing of insulin by pharmaceutical companies and pharmacy benefit managers.